http://orcid.org/0000-0003-1835-2883
Figures
Abstract
Mitochondrial Ca2+ is a key regulator of organelle physiology and the excessive increase in mitochondrial calcium is associated with the oxidative stress. In the present study, we investigated the molecular mechanisms linking mitochondrial calcium to inflammatory and coagulative responses in hepatocytes exposed to high glucose (HG) (33mM glucose). Treatment of HepG2 cells with HG for 24 h induced insulin resistance, as demonstrated by an impairment of insulin-stimulated Akt phosphorylation. HepG2 treatment with HG led to an increase in mitochondrial Ca2+ uptake, while cytosolic calcium remained unchanged. Inhibition of MCU by lentiviral-mediated shRNA prevented mitochondrial calcium uptake and downregulated the inflammatory (TNF-α, IL-6) and coagulative (PAI-1 and FGA) mRNA expression in HepG2 cells exposed to HG. The protection from HG-induced inflammation by MCU inhibition was accompanied by a decrease in the generation of reactive oxygen species (ROS). Importantly, MCU inhibition in HepG2 cells abrogated the phosphorylation of p38, JNK and IKKα/IKKβ in HG treated cells. Taken together, these data suggest that MCU inhibition may represent a promising therapy for prevention of deleterious effects of obesity and metabolic diseases.
Citation: Panahi G, Pasalar P, Zare M, Rizzuto R, Meshkani R (2018) MCU-knockdown attenuates high glucose-induced inflammation through regulating MAPKs/NF-κB pathways and ROS production in HepG2 cells. PLoS ONE 13(4): e0196580. https://doi.org/10.1371/journal.pone.0196580
Editor: Makoto Kanzaki, Tohoku University, JAPAN
Received: December 13, 2017; Accepted: April 16, 2018; Published: April 30, 2018
Copyright: © 2018 Panahi et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the paper.
Funding: This work was financially supported by a grant (93-01-30-25164) from the Deputy of Research, Tehran University of Medical Sciences.
Competing interests: The authors have declared that no competing interests exist.
Abbreviations: HG, high glucose; NG, normal glucose; PAI-1, Plasminogen activator inhibitor-1; TNF-α, Tumor Necrosis Factor alpha; IL-6, Interleukin 6; NF-κB, Nuclear Factor kappa-light-chain-enhancer of activated B cells; IKK, IκB kinase; MAPK, Mitogen-Activated Protein Kinases; JNK, c-Jun N-terminal kinase; ERK, Extracellulare signal-Regulated Kinases; ROS, Reactive Oxygen Species; MCU, Mitochondrial Calcium Uniporter; T2D, Type 2 Diabetes
Introduction
The evidence suggests that insulin resistance in skeletal muscle, adipose and liver tissues plays an important role in development and initiation of type 2 diabetes (T2D) [1]. In recent years, there has been strong evidence that hyperglycemia, hyperinsulinemia, hyperlipidemia, and pro-inflammatory states contribute to development of insulin resistance [2]. The liver as a vital member of the vertebrates plays a central role in coordination of the entire metabolism. Some of the main functions of the liver include gluconeogenesis, glycogenolysis, glycogenesis, lipogenesis, cholesterol synthesis, synthesis of blood coagulation factors such as fibrinogen and plasminogen activator inhibitor-1 (PAI-1). Liver insulin resistance leads to increased production of glucose, lipoproteins, inflammatory factors such as TNF-α and interleukin 6 (IL-6), and coagulation factors such as fibrinogen A (FGA), fibrinogen B (FGB) and plasminogen activator inhibitor-1 (PAI). The consequence of these disorders is to exacerbate insulin resistance in the liver, as well as in peripheral tissues [3]. Hyperglycemia is considered as one of the most important causes of insulin resistance in liver cells. Glucose toxicity has been proposed to induce insulin resistance by different mechanisms including the formation of advanced glycosylation end products (AGEs), glucosamine production, increased protein kinase C activity, glucose auto-oxidation and a moderate increase in the level of glycolytic reactions [4]. All of these processes are usually involved in the formation of reactive oxygen species (ROS) [5]. On the other hand, inflammation is one of the most important factors in the pathogenesis of hepatic insulin resistance. A number of epidemiological and animal studies have examined the relationship between hepatic insulin resistance and increased production of inflammatory factors such as TNF-α and IL-6 [6, 7].
One critical function of the liver is the integration of multiple signals to maintain normal blood glucose levels. Many of the functions of the liver including glucose metabolism, biliary secretion, mitochondrial physiology, and cell regeneration are regulated by Ca+2 [8]. Cytoplasmic calcium fluctuations play a crucial role in regulating these signals. One of the mechanisms controlling the cytoplasmic calcium fluctuations is the absorption of calcium by mitochondria [9]. Ca2+ uptake into mitochondria is mediated by the “mitochondrial calcium uniporter,” (MCU) a multisubunit Ca2+ channel complex [10]. Mitochondrial Ca2+ regulates several basic biological functions, including the efficiency of mitochondrial ATP production and the onset of mitochondria-mediated cell death [10]. The excessive increase in mitochondrial calcium is also associated with the pathological conditions such as apoptosis or necrosis [11]. It was reported that increase in mitochondrial Ca+ 2 is associated with the accumulation of ROS, leading to the stable opening of the permeability transfer pores sensitive to cyclosporine (PTP), causing a rapid decomposition of ΔΨm and mitochondrial swelling, loss of pyridine nucleotides and cytochrome c, ATP drainage and ultimately cell death [12]. Given the crucial role of mitochondrial calcium in generation of ROS and because high glucose, known as inducer of pro-inflammatory responses, has been implicated in oxidative stress conditions, we in the present study questioned whether mitochondrial calcium is involved in high glucose (HG)-induced inflammatory and coagulative responses in HepG2 cells. In this study we evaluated the effect of mitochondrial calcium inhibition on the expression of pro-inflammatory and coagulation factors in HepG2 cells exposed to high concentration of glucose.
Methods & material
Materials
Dulbecco’s modified Eagle’s medium (DMEM), fetal bovine serum (FBS), and trypsin EDTA were purchased from Gibco (Gibco, Germany). Tissue culture flasks and disposable plastic ware purchased from Greiner Bio-One (Frickenhausen, Germany). N-Acetyl-L-cysteine and secondary antibodies were purchased from Sigma Aldrich (Taufkirchen, Germany). All primary antibodies were purchased from Abcam (Cambridge, UK). Polyvinylidene difluoride (PVDF) membrane was from Millipore (Schwal-bach, Germany). ECL reagents were from Amersham Pharmacia Corp. (Piscataway, NJ, USA). DHE and MitoSOX red were from Invitrogen (San Diego, CA, USA).
Cell culture and lentivirus infection
HepG2 and HEK T293 cells were purchased from the Iranian Biological Resource Center (IBRC). Cells were cultured at 37°C (in an atmosphere of 5% CO2) in DMEM containing 10% FBS, and 1% penicillin–streptomycin. In order to induce insulin resistance, HepG2 cells were treated with 33 mM d-glucose (HG). d-mannitol (27.5 mM mannitol) was used as an osmotic control in normal glucose (NG) (5.5mM glucose) treated sells. Selection of the time and dose of glucose treatment were based on previously published study [13].
Lentiviruses were prepared as previously described [13]. Briefly, the transfer and packaging (PMD2 and PUMVC) plasmids were transfected into T293 packaging cells. Viral supernatants were collected after 48–72 h transfection and filtered on 0.44 μm filters. HepG2 cells were infected with viral supernatants of SC (scramble) and shRNA-MCU in the presence of 10 μg/ml polybrene for 48 hours.
Real time PCR
RNA was isolated using GeneAll RibospinTM total RNA purification kit (GeneAll Biotechnology, South Korea). Complementary DNA (cDNA) was reverse transcribed using a RevertAid First Strand cDNA Synthesis Kit (Thermo Fisher Scientific). Gene expression analysis was evaluated by qRT-PCR using SYBR Green RealQ Plus 2x Master Mix Green (Ampliqon) on Corbett Rotor Gene 6000 Light Cycler (Qiagen, Hilden, Germany). The levels of the target gene transcripts were normalized relative to β-actin. The 2^-dCt method was used to calculate the relative expression.
Western blot analysis
Western-blot analysis was carried out according to our previous report [14]. The antibodies used were MCU, p-JNK, p-ERK, p-P38, JNK, ERK, p38 and Ikkα/β (Cell Signaling Technology, Beverly, MA, USA) and β-actin (Abcam, Cambridge, MA, USA)
Measurement of intracellular reactive oxygen species (ROS) level
CM-H2DCFDA (Life Technologies) was used in the measurement of the ROS production. Briefly, HepG2 cells were washed twice with PBS and then incubated with CM-H2DCFDA for 30min, rinsed, and fluorescence measured. MitoSOX red indicator (Life Technologies) was used to measure mitochondrial superoxide. Briefly, cells were incubated in MitoSOX for 15min, rinsed, and fluorescence time course measured. Fluorescence was measured using both a Carl Zeiss Axiovert 200M Inverted Microscope and an Envision Multilabel Plate Reader (Perkin Elmer, Milan, Italy).
Calcium measurements
HepG2 cells on a 96 well plate were infected with the adenoviruses expressing the cytosolic (Ad‐cytAEQ) or the low-affinity mitochondrial probe (Ad‐mtAEQmut) [15]. Ad-GFP was used as control for adenoviral transduction. The plates were incubated with 5μM coelenterazine for 1–2 h in Krebs-Ringer modified buffer supplemented with 1mM CaCl2. All aequorin measurements were carried out in krebs-ringer bicarbonate buffer. 100nM bradykinin was used to stimulate Ca2+ release. All the experiments were terminated by cell lysis with 100 μM digitonin in a hypotonic Ca2+-rich solution (10 mM CaCl2 in H2O) to discharge the remaining reconstituted active aequorin pool. Signals were measured using an Envision Multilabel Plate Reader (Perkin Elmer, Milan, Italy).
Statistical analyses
All statistical analyses were conducted using SPSS22. (SPSS, Chicago, IL, USA). Statistical significance was considered at p<0.05. Comparisons among all groups were performed with the one-way analysis of variance with Tukey’s HSD post-test when appropriate. Results are expressed as the mean±SEM of at least three independent experiments.
Results
Because of the close link between the oxidative stress and mitochondrial calcium uptake [16], we first studied the correlation between hepatic insulin resistance and changes in mitochondrial calcium homeostasis. Insulin-stimulated Akt phosphorylation reduced after 24 h treatment of HepG2 cells with 33mM glucose (HG) indicating the development of hepatic insulin resistance (Fig 1A). HG treatment led to a marked increase in mitochondrial Ca2+ uptake (+75%, Fig 1B), while cytosolic Ca2+ remained unchanged (Fig 1C), demonstrating an increased mitochondrial calcium uptake in insulin resistance condition.
A: The effect of 33mM glucose (HG) on Akt phosphorylation was performed by western blotting method. B&C: The effect of HG on mitochondrial calcium was assessed using the adenoviruses expressing the low-affinity mitochondrial probe. D&G: The effect of HG on cytosolic calcium was evaluated by adenoviruses expressing the cytosolic probe. Data are shown as a mean ± SEM of at least three separate experiment. NG: normal glucose, HG: high glucose, # <0.05, * <0.01, NS = not significance.
Metabolic inflammation is a major player in the development of hepatic insulin resistance [6]. Given the link between high glucose condition and increased mitochondrial calcium in HepG2 cells, we then investigated whether there is an association between MCU and inflammatory cytokines and coagulation factors in hepatocytes. To assess the functional significance of MCU in hepatocytes inflammation, we generated a stable cell line where the expression of MCU was silenced. Lentiviral-mediated shRNA knockdown of MCU in HepG2 resulted in a decrease of mRNA and protein levels of MCU by 70 and 87%, respectively (Fig 2A and 2B). MCU inhibition also reduced HG-induced mitochondrial calcium in HepG2 cells (Fig 2C). Treatment of hepatocytes with HG resulted in a 35% reduction in p-Akt compared to controls, whereas MCU inhibition completely reverted this effect (Fig 2D). We observed that while HG induces the expression of inflammatory and coagulation factors, MCU inhibition resulted in a decrease of TNF-α, IL-6, PAI-1, FGA and FGB expression in HG-treated cells (Fig 2E–2H). These data suggest a strong association between the pro-inflammatory and coagulative responses and mitochondrial Ca2+ uptake in liver cells.
HepG2 stable cells were generated by infecting the cells with the supernatants of lentiviruses expressing MCU shRNA. Real-time PCR and western blotting were used to detect MCU mRNA and protein levels in HepG2 stable cells, respectively. A: Protein levels of MCU, B: mRNA level of MCU, C) mitochondrial calcium concentration in MCU-KD cells. D: the effect of MCU inhibition on the mRNA expression of TNF-α (E), IL-6 (F), PAI-1 (G), FGA (H), and FGB(I) were measured using real time PCR. Data are shown as a mean ± SEM of at least three separate experiment. MCU-KD: MCU knockdown cells, SC: Scramble, NG: normal glucose, HG: high glucose, # <0.05, * <0.01, * * <0.001.
We next sought to identify the mechanism underlying the observed reducing effect of MCU inhibition on hepatic inflammation. Since high glucose is the major cause of oxidative stress, we measured ROS level, the production of which largely relies on the activity of the mitochondrial electron transport complexes. HG treatment results in an increase of both intracellular and mitochondrial ROS levels using DCFDA and MitoSOX dyes, respectively (Fig 3A and 3B). We also observed that MCU knock-down cells exhibited a decrease in ROS level suggesting the key role of MCU in regulating the oxidative stress (Fig 3A and 3B).
HepG2 cells were treated with HG for 24 h. A: H2O2 levels were measured using flow cytometry with DCFH-DA. B: Mitochondrial ROS level using MitoSOX red dye. Data are shown as a mean ± SEM of at least three separate experiment.: MCU knockdown cells, SC: Scramble, NG: normal glucose, HG: high glucose, # <0.05, * <0.01, * * <0.001.
Oxidative stress has been shown to induce the inflammatory and coagulative responses by activating the mitogen-activated protein kinases (MAPKs) and nuclear Factor kappa-light-chain-enhancer of activated B cells (NF-kB) pathways [17]. To elucidate the mechanism by which MCU knockdown relieved the increase of inflammation induced by HG, we examined the phosphorylation levels of MAPKs and IKK: IκB kinase (IKKα/IKKβ) in HepG2 cells over HG stimulation. We found that MCU inhibition attenuated HG-induced phosphorylation of c-Jun N-terminal kinase (JNK) and p38, but not extracellulare signal-regulated kinases (ERK) in HepG2 cells (Fig 4A–4C). The level of p-IKKα/IKKβ was also diminished in MCU-knockdown cells treated with HG (Fig 4D). These results suggest that MCU inhibition prevented HG-induced inflammation in HepG2 cells by mechanisms involving the decreasing the activity of the JNK, p38 and NF-κB pathways.
HepG2 cells were treated with HG for 24 h. After treatment, cells were lysed and protein extracts were immunoblotted with specific antibodies. The effect of MCU inhibition on JNK (A), P38 (B), ERK (C) and IKKα-β (D) phosphorylation has been demonstrated. Data are shown as a mean ± SEM of at least three separate experiment. MCU knockdown cells, SC: Scramble, NG: normal glucose, HG: high glucose, # <0.05, * <0.01, * * <0.001.
Discussion
The liver plays a central role in inflammation through its ability to produce acute anti-inflammatory phase proteins and inflammatory cytokines via Kupffer cells and resident lymphocytes [18]. There is evidence that in addition to Kupffer cells and lymphocytes in the liver, hepatocytes can also secrete pro-inflammatory cytokines when they are stimulated by inflammatory markers or fatty acids [19]. The research during the past decades has revealed the mechanism by which hyperglycemia-induced oxidative stress leads to chronic inflammation [20]. On the other hand, mitochondrial Ca2+ overload has been reported to induce oxidative stress by increasing production of ROS [21]. Therefore, we in the present study aimed to investigate the role of mitochondrial calcium in inflammatory and coagulative responses in hepatocytes by targeting the MCU, a transmembrane protein that allows the passage of calcium ions from the cytosol into mitochondria.
In this study we first investigated the subcellular calcium flux in HG-treated hepatocytes. Chronic HG was associated with a 49% increase in mitochondrial Ca2+, while cytosolic Ca2+ remained stable. This result is in the line with the data obtained from previous studies. Jorge Suarez et al. showed that calcium transients in cardiomyocytes exposed to HG for 48 h were prolonged compared with transients of the cells cultured in NG [22]. Sand Kim Kumar et al. also observed that HG induces calcium accumulation in the mitochondria of cardiomyocyte H9c2 cells in a time-dependent manner [23]. Mitochondria play significant roles in shaping the Ca2+signal released from the endoplasmic reticulum (ER) [24]. Under normal physiological conditions, the bulk of the Ca2+ resides within the ER lumen and, during cellular events requiring a Ca2+ signal, a small proportion crossing the outer mitochondrial membrane. In pathological conditions such as ER stress, increased release of Ca2+ from the ER result in massive and/or a prolonged mitochondrial Ca2+ overload [25] In this regard, various pathological conditions including ER stress, oxidative stress, palmitate, and chronic high glucose decreased ER calcium levels in pancreatic β cells [26]. Importantly, the rate of ER calcium-depleted β cells was increased by chronic high glucose [26]. Therefore, because of the stable condition of cytosolic calcium in HG treatment, it appears that increased mitochondrial calcium observed in this study results from increased release of calcium from ER to mitochondria. However, further studies are required to confirm this idea.
In the following experiments, we investigated the relationship between mitochondrial calcium accumulation and the inflammatory and coagulative responses in HepG2 cells by inactivation of MCU. In consistent with the results of the other studies, we found that a 70% decrease of MCU expression was associated with 78% reduction of the absorption of calcium by mitochondria [27]. Insulin-sensitive MCU-knockdown cells exhibited a drastic reduction in the expression of TNF-α, IL-6, PAI-1, FGA and FGB. In agreement with our findings, a recent study reported that a decrease of mitochondrial calcium by Mcub-overexpressing in adipocytes led to a reduction in the release of TNF-α and IL-6 [16]. Furthermore, it was suggested that accumulation of calcium in the mitochondria matrix through the MCU triggers nod-like receptor protein 3 (NLRP3) inflammasome activation and IL-1β release in lung epithelial cells [28]. All together, these data demonstrate a link between mitochondrial calcium and inflammation, thus suggesting a possible role for MCU in the development of obesity-associated metabolic inflammation.
Oxidative stress has been proposed to link with the inflammatory responses. In this regard, it has been demonstrated that ROS can trigger the activation of NF-κB and MAPKs signaling pathways resulting in an increase of the inflammatory processes in various cell types [29, 30]. To investigate the molecular mechanism underlying the anti-inflammatory effect of MCU inhibition, we targeted the oxidative stress and the signaling pathways of MAPKs and NF-kB. In this study HG could promote generation of ROS in HepG2 cells. In support of this finding, it has been demonstrated that oxidative stress was increased following treatment of HepG2 cells with high glucose [31]. MCU inhibition could attenuate HG-induced ROS production in HepG2 cells. Mitochondria are an important source of ROS within most mammalian cells [32]. Given that MCU inhibition completely blocked HG-induced MitoSOX intensity in HepG2 cells, therefore it is plausible to suggest that MCU inactivation may suppress the inflammatory responses by inhibiting mitochondrial ROS production in HepG2 cells. In accordance with this notion, it was reported that decreasing mitochondrial calcium could affect mitochondrial metabolism including the activity of oxidative enzymes, mitochondrial respiration, membrane potential, and ROS production in adipocytes [16]. In the following experiments, we found that HG could induce the phosphorylation of JNK and P38 in HepG2 cells. It is worthy note that a role for JNK and P38 in regulating the inflammatory processes has been previously reported in skeletal muscle and adipose tissues [33, 34]. Interestingly, we were able to demonstrate that MCU inhibition could attenuate HG-induced phosphorylation of JNK and P38. In parallel with the previous reports, we found that HG activates NF-κB pathway as demonstrated by an increased phosphorylation of IKKα/IKKβ [35]. Enhanced phosphorylation of IKKα/IKKβ leads to degradation of IκB protein and subsequent release of NF-κB to translocate to the nucleus [36]. Importantly, we found that MCU inhibition decreased HG-increased phosphorylation of IKKα/IKKβ and thereby NF-κB activity. Collectively, the present data suggest that MCU inhibition ameliorates HG-induced inflammation in HepG2 cells by attenuating oxidative stress and decreasing the activity of JNK, P38 and NF-ΚB pathways. Because of the cancerous nature of the HepG2 cells used in this study, our findings need to be interpreted cautiously and the data should be confirmed in another cell line or primary hepatocytes. However, in support of the data of this study, we should note that HepG2 cells have been widely used as a model of insulin resistance. These cells have ability to synthesize and release bile acids, secrete plasma proteins such as albumin, alpha-fetoprotein, fibrinogen, and apolipoproteins and have receptor for asialoglycoprotein, insulin, transferrin, estrogen, low density lipoprotein (LDL), and high density lipoprotein (HDL) [37–40]. More importantly, a similar profile of the inflammatory responses to different stimuli such as lipopolysaccharide (LPS) and palmitate was reported from HepG2 cells and primary hepatocytes [19, 41].
Akt is responsible primarily for many of the metabolic actions of insulin [42]. Not surprising, therefore, the depression of Akt activation significantly correlated with the increase of insulin resistance condition. In this regard, mice lacking both hepatic isoforms (Akt1:Akt2) show marked glucose intolerance and insulin resistance [43]. Studies have found that chronic and/or increased production of ROS triggers the activation of serine/threonine kinase cascades such as JNK, NF-kB, and others that in turn phosphorylate multiple targets, including the insulin receptor and the insulin receptor substrate (IRS) proteins. Increased serine phosphorylation of IRS and subsequently decreased phosphorylation of Akt explains the molecular basis of oxidative stress-induced insulin resistance [44]. In the present study we observed a lower Akt phosphorylation in HG treated cells. MCU inhibition reversed the effect of HG on Akt phosphorylation indicating an increase in insulin sensitivity of MCU-KD cells. According to above mentioned scenario, our findings of lower mitochondrial calcium and subsequently decrease of oxidative stress, decrease of MAPKs and NF-KB activations may explain the molecular mechanism linking MCU inhibition and increased Akt phosphorylation in MCU-KD cells exposed to chronic HG.
In conclusion, here we demonstrated an association between mitochondrial calcium and the inflammatory and coagulative responses in a model of insulin resistance. Normalizing mitochondrial calcium by inhibiting MCU in HepG2 cells attenuated HG-induced insulin resistance and inflammation by mechanisms involving the inhibition of ROS production and decreasing the activity of the MAPKs and NF-κB signaling pathways. The data suggest that MCU inhibition may represent a promising therapy for prevention of deleterious effects of obesity and metabolic diseases.
References
- 1. Spellman CW. Pathophysiology of type 2 diabetes: targeting islet cell dysfunction. J Am Osteopath Assoc. 2010;110(3 Suppl 2):S2–7. Epub 2010/04/23. 110/3_suppl_2/S2 [pii]. pmid:20382838.
- 2. Hundal RS, Petersen KF, Mayerson AB, Randhawa PS, Inzucchi S, Shoelson SE, et al. Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J Clin Invest. 2002;109(10):1321–6. Epub 2002/05/22. pmid:12021247; PubMed Central PMCID: PMC150979.
- 3. Bastard J-P, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. European cytokine network. 2006;17(1):4–12. pmid:16613757
- 4. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414(6865):813–20. pmid:11742414
- 5. Dröge W. Free radicals in the physiological control of cell function. Physiological reviews. 2002;82(1):47–95. pmid:11773609
- 6. Meshkani R, Vakili S. Tissue resident macrophages: Key players in the pathogenesis of type 2 diabetes and its complications. Clinica chimica acta; international journal of clinical chemistry. 2016;462:77–89. Epub 2016/10/19. pmid:27570063.
- 7. Robinson MW, Harmon C, O'Farrelly C. Liver immunology and its role in inflammation and homeostasis. Cellular & molecular immunology. 2016;13(3):267–76. Epub 2016/04/12. pmid:27063467; PubMed Central PMCID: PMCPMC4856809.
- 8. Lagoudakis L, Garcin I, Julien B, Nahum K, Gomes DA, Combettes L, et al. Cytosolic calcium regulates liver regeneration in the rat. Hepatology. 2010;52(2):602–11. pmid:20683958
- 9. Berridge MJ, Lipp P, Bootman MD. The versatility and universality of calcium signalling. Nature reviews Molecular cell biology. 2000;1(1):11–21. pmid:11413485
- 10. Tsai C-W, Wu Y, Pao P-C, Phillips CB, Williams C, Miller C, et al. Proteolytic control of the mitochondrial calcium uniporter complex. Proceedings of the National Academy of Sciences. 2017:201702938.
- 11. De Stefani D, Raffaello A, Teardo E, Szabo I, Rizzuto R. A forty-kilodalton protein of the inner membrane is the mitochondrial calcium uniporter. Nature. 2011;476(7360):336–40. http://www.nature.com/nature/journal/v476/n7360/abs/nature10230.html#supplementary-information. pmid:21685888
- 12. Orrenius S, Zhivotovsky B, Nicotera P. Regulation of cell death: the calcium-apoptosis link. Nat Rev Mol Cell Biol. 2003;4(7):552–65. Epub 2003/07/03. [pii]. pmid:12838338.
- 13. Taheripak G, Bakhtiyari S, Rajabibazl M, Pasalar P, Meshkani R. Protein tyrosine phosphatase 1B inhibition ameliorates palmitate-induced mitochondrial dysfunction and apoptosis in skeletal muscle cells. Free radical biology & medicine. 2013;65:1435–46. Epub 2013/10/15. pmid:24120971.
- 14. Vakili S, Ebrahimi SS, Sadeghi A, Gorgani-Firuzjaee S, Beigy M, Pasalar P, et al. Hydrodynamic-based delivery of PTP1B shRNA reduces plasma glucose levels in diabetic mice. Molecular medicine reports. 2013;7(1):211–6. pmid:23138128.
- 15. Pinton P, Rimessi A, Romagnoli A, Prandini A, Rizzuto R. Biosensors for the detection of calcium and pH. Methods in cell biology. 2007;80:297–325. Epub 2007/04/21. pmid:17445701.
- 16. Wright LE, Reane DV, Milan G, Terrin A, di Bello G, Belligoli A, et al. Increased mitochondrial calcium uniporter in adipocytes underlies mitochondrial alterations associated with insulin resistance. American Journal of Physiology-Endocrinology and Metabolism. 2017:ajpendo. 00143.2016.
- 17. Gaitanaki C, Konstantina S, Chrysa S, Beis I. Oxidative stress stimulates multiple MAPK signalling pathways and phosphorylation of the small HSP27 in the perfused amphibian heart. The Journal of experimental biology. 2003;206(Pt 16):2759–69. Epub 2003/07/09. pmid:12847121.
- 18. Sheth K, Bankey P. The liver as an immune organ. Current opinion in critical care. 2001;7(2):99–104. pmid:11373518
- 19. Dong W, SIMEONOVA PP, GALLUCCI R, MATHESON J, FANNIN R, MONTUSCHI P, et al. Cytokine expression in hepatocytes: role of oxidant stress. Journal of interferon & cytokine research. 1998;18(8):629–38.
- 20. Hardbower DM, de Sablet T, Chaturvedi R, Wilson KT. Chronic inflammation and oxidative stress: The smoking gun for Helicobacter pylori-induced gastric cancer? Gut Microbes. 2013;4(6):475–81. PMC3928159. pmid:23811829
- 21. Peng TI, Jou MJ. Oxidative stress caused by mitochondrial calcium overload. Annals of the New York Academy of Sciences. 2010;1201:183–8. Epub 2010/07/24. pmid:20649555.
- 22. Suarez J, Hu Y, Makino A, Fricovsky E, Wang H, Dillmann WH. Alterations in mitochondrial function and cytosolic calcium induced by hyperglycemia are restored by mitochondrial transcription factor A in cardiomyocytes. American Journal of Physiology-Cell Physiology. 2008;295(6):C1561–C8. pmid:19060297
- 23. Kumar S, Kain V, Sitasawad SL. High glucose-induced Ca 2+ overload and oxidative stress contribute to apoptosis of cardiac cells through mitochondrial dependent and independent pathways. Biochimica et Biophysica Acta (BBA)-General Subjects. 2012;1820(7):907–20.
- 24. Malhotra JD, Kaufman RJ. ER stress and its functional link to mitochondria: role in cell survival and death. Cold Spring Harbor perspectives in biology. 2011;3(9):a004424. pmid:21813400
- 25.
Romagnoli A, Aguiari P, De Stefani D, Leo S, Marchi S, Rimessi A, et al., editors. Endoplasmic reticulum/mitochondria calcium cross-talk. Novartis Foundation symposium; 2007: Chichester; New York; John Wiley; 1999.
- 26. Hara T, Mahadevan J, Kanekura K, Hara M, Lu S, Urano F. Calcium efflux from the endoplasmic reticulum leads to beta-cell death. Endocrinology. 2014;155(3):758–68. Epub 2014/01/16. pmid:24424032; PubMed Central PMCID: PMCPMC3929724.
- 27. Baughman JM, Perocchi F, Girgis HS, Plovanich M, Belcher-Timme CA, Sancak Y, et al. Integrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporter. Nature. 2011;476(7360):341. pmid:21685886
- 28. Triantafilou K, Hughes TR, Triantafilou M, Morgan BP. The complement membrane attack complex triggers intracellular Ca2+ fluxes leading to NLRP3 inflammasome activation. J Cell Sci. 2013;126(13):2903–13.
- 29. Park GB, Choi Y, Kim YS, Lee HK, Kim D, Hur DY. ROS-mediated JNK/p38-MAPK activation regulates Bax translocation in Sorafenib-induced apoptosis of EBV-transformed B cells. International journal of oncology. 2014;44(3):977–85. Epub 2014/01/10. pmid:24402682.
- 30. Maloney E, Sweet IR, Hockenbery DM, Pham M, Rizzo NO, Tateya S, et al. Activation of NF-kappaB by palmitate in endothelial cells: a key role for NADPH oxidase-derived superoxide in response to TLR4 activation. Arteriosclerosis, thrombosis, and vascular biology. 2009;29(9):1370–5. Epub 2009/06/23. pmid:19542021; PubMed Central PMCID: PMCPMC2775080.
- 31. Gautier-Stein A, Soty M, Chilloux J, Zitoun C, Rajas F, Mithieux G. Glucotoxicity induces glucose-6-phosphatase catalytic unit expression by acting on the interaction of HIF-1α with CREB-binding protein. Diabetes. 2012;61(10):2451–60. pmid:22787137
- 32. Murphy MP. How mitochondria produce reactive oxygen species. Biochemical Journal. 2009;417(1):1–13. pmid:19061483
- 33. Baeza-Raja B, Munoz-Canoves P. p38 MAPK-induced nuclear factor-kappaB activity is required for skeletal muscle differentiation: role of interleukin-6. Mol Biol Cell. 2004;15(4):2013–26. Epub 2004/02/10. E03-08-0585 [pii]. pmid:14767066; PubMed Central PMCID: PMC379295.
- 34. Wang SL, Li Y, Wen Y, Chen YF, Na LX, Li ST, et al. Curcumin, a potential inhibitor of up-regulation of TNF-alpha and IL-6 induced by palmitate in 3T3-L1 adipocytes through NF-kappaB and JNK pathway. Biomed Environ Sci. 2009;22(1):32–9. Epub 2009/05/26. S0895-3988(09)60019-2 [pii] pmid:19462685.
- 35. Ramana KV, Friedrich B, Srivastava S, Bhatnagar A, Srivastava SK. Activation of nuclear factor-kappaB by hyperglycemia in vascular smooth muscle cells is regulated by aldose reductase. Diabetes. 2004;53(11):2910–20. Epub 2004/10/27. pmid:15504972.
- 36. Tak PP, Firestein GS. NF-kappaB: a key role in inflammatory diseases. J Clin Invest. 2001;107(1):7–11. Epub 2001/01/03. pmid:11134171; PubMed Central PMCID: PMC198552.
- 37. Bouma M-E, Rogier E, Verthier N, Labarre C, Feldmann G. Further cellular investigation of the human hepatoblastoma-derived cell line HepG2: morphology and immunocytochemical studies of hepatic-secreted proteins. In vitro cellular & developmental biology. 1989;25(3):267–75.
- 38. Everson G, Polokoff M. HepG2. A human hepatoblastoma cell line exhibiting defects in bile acid synthesis and conjugation. Journal of Biological Chemistry. 1986;261(5):2197–201. pmid:3003100
- 39. Hoeg JM, Demosky SJ, Edge SB, Gregg RE, Osborne JC, Brewer HB. Characterization of a human hepatic receptor for high density lipoproteins. Arteriosclerosis, thrombosis, and vascular biology. 1985;5(3):228–37.
- 40. Knowles BB, Howe CC, Aden DP. Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science. 1980;209(4455):497–9. pmid:6248960
- 41. Rowell DL, Eckmann L, Dwinell MB, Carpenter SP, Raucy J, Yang S, et al. Human hepatocytes express an array of proinflammatory cytokines after agonist stimulation or bacterial invasion. American Journal of Physiology-Gastrointestinal and Liver Physiology. 1997;273(2):G322–G32.
- 42. Di Paolo S, Teutonico A, Leogrande D, Capobianco C, Schena PF. Chronic inhibition of mammalian target of rapamycin signaling downregulates insulin receptor substrates 1 and 2 and AKT activation: a crossroad between cancer and diabetes? Journal of the American Society of Nephrology. 2006;17(8):2236–44. pmid:16807405
- 43. Lu M, Wan M, Leavens KF, Chu Q, Monks BR, Fernandez S, et al. Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1. Nature medicine. 2012;18(3):388. pmid:22344295
- 44. Evans JL, Maddux BA, Goldfine ID. The molecular basis for oxidative stress-induced insulin resistance. Antioxidants & redox signaling. 2005;7(7–8):1040–52.